Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases
Rivus’ fat-trimming therapy nabs $35M to harness our own biology [...]
In an unusual crossover, Gilead hires Arcus CMO Grossman, putting him in charge of cancer pact with his former biotech
In an unusual crossover, Gilead hires Arcus CMO Grossman, putting [...]
Panakès moves into biotech investing with new €150M fund
Panakès moves into biotech investing with new €150M fund ntaylor [...]
Surprise genetic discovery in macular degeneration points to new treatment strategy
Surprise genetic discovery in macular degeneration points to new treatment [...]
Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”
Rome, backed by Arch and GV, hires science leaders to [...]
Adagio seeks IPO to bring COVID-19 antibody to market in 2022
Adagio seeks IPO to bring COVID-19 antibody to market in [...]
Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims to add 1,000 new staffers over 5 years
Regeneron plans $1.8B upgrade at Tarrytown campus, where it aims [...]
Polyphor sharpens ax on staff, shutters failed breast cancer test
Polyphor sharpens ax on staff, shutters failed breast cancer test [...]
GSK sells off part of its U.K. R&D site to rake in $554M and boost biotech ops
GSK sells off part of its U.K. R&D site to [...]
ACB hires Liu from Eureka Therapeutics to lead push into clinic
ACB hires Liu from Eureka Therapeutics to lead push into [...]